๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy and safety of Zonisamide as first add-on therapy in adult patients with partial, generalized and combined seizures

โœ Scribed by Dash, A.; Rawat, S.S.; Jyothi, B.; Demudubabu, B.; Kumar, V.; Bajpai, V.; Ghatule, R.

Book ID
121965326
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
62 KB
Volume
333
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A double-blind, placebo-controlled evalu
A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures
โœ T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J M ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 655 KB

Sixty-two patients with uncontrolled partial seizures participated in a 12-week, double-blind, placebo-controlled add-on-trial. Thirty-two patients received loreclezole and 30 a placebo as add-on therapy. Loreclezole was targeted at a plasma level of 1-2 mg/l. In spite of an antiepileptic therapy, u

Long-term evaluation of the efficacy and
Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up
โœ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations